Cas:672937-60-9 2-(Dicyclohexylphosphino)-1-phenyl-1H-pyrrole manufacturer & supplier

We serve Chemical Name:2-(Dicyclohexylphosphino)-1-phenyl-1H-pyrrole CAS:672937-60-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(Dicyclohexylphosphino)-1-phenyl-1H-pyrrole

Chemical Name:2-(Dicyclohexylphosphino)-1-phenyl-1H-pyrrole
CAS.NO:672937-60-9
Synonyms:dicyclohexyl-(1-phenylpyrrol-2-yl)phosphane
Molecular Formula:C22H30NP
Molecular Weight:339.45400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:18.52000
Exact Mass:339.21200
LogP:6.24990

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like dicyclohexyl-(1-phenylpyrrol-2-yl)phosphane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dicyclohexyl-(1-phenylpyrrol-2-yl)phosphane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,dicyclohexyl-(1-phenylpyrrol-2-yl)phosphane Use and application,dicyclohexyl-(1-phenylpyrrol-2-yl)phosphane technical grade,usp/ep/jp grade.


Related News: RELATED: With Takhzyro durability data, Takeda tries to fend off BioCryst’s hereditary angioedema challenger Orladeyo 6-((8-(23,34,43,53-pentaoxol-3-yl)-14,23,33,43,54,63,73,84,93,104-hexaoxino[6,1]hexaoxin-1-yl)oxy)-13,23,34,44,53,64-hexaoxine-3,4-diol manufacturers AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023. 2-(m-acetoxyphenyl)imidazo[2,1-b]benzothiazole suppliers As for the expansion itself, Takeda will build a new 15,000-square-foot manufacturing facility at the site and expand an existing 14,000-square-feet of production space. Takeda has been knocking around the Thousand Oaks area since 1996, the Business Times said. N-trimethylsilylethanesulfonamide vendor & factory The company pinpointed Thousand Oaks for its expansion “based on capability, staffing as well as the local community and the things we could bring to the area,” Hatke, told the news outlet.,AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023.